427 related articles for article (PubMed ID: 17683826)
21. Development of biodegradable nanoparticles for liver-specific ribavirin delivery.
Ishihara T; Kaneko K; Ishihara T; Mizushima T
J Pharm Sci; 2014 Dec; 103(12):4005-4011. PubMed ID: 25335768
[TBL] [Abstract][Full Text] [Related]
22. Development of surface modified biodegradable polymeric nanoparticles to deliver GSE24.2 peptide to cells: a promising approach for the treatment of defective telomerase disorders.
Egusquiaguirre SP; Manguán-García C; Pintado-Berninches L; Iarriccio L; Carbajo D; Albericio F; Royo M; Pedraz JL; Hernández RM; Perona R; Igartua M
Eur J Pharm Biopharm; 2015 Apr; 91():91-102. PubMed ID: 25660910
[TBL] [Abstract][Full Text] [Related]
23. Fabrication of multi-layered biodegradable drug delivery device based on micro-structuring of PLGA polymers.
Ryu WH; Vyakarnam M; Greco RS; Prinz FB; Fasching RJ
Biomed Microdevices; 2007 Dec; 9(6):845-53. PubMed ID: 17577671
[TBL] [Abstract][Full Text] [Related]
24. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
[TBL] [Abstract][Full Text] [Related]
25. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
[TBL] [Abstract][Full Text] [Related]
26. Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives.
Pandita D; Kumar S; Lather V
Drug Discov Today; 2015 Jan; 20(1):95-104. PubMed ID: 25277320
[TBL] [Abstract][Full Text] [Related]
27. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
Parajó Y; d'Angelo I; Horváth A; Vantus T; György K; Welle A; Garcia-Fuentes M; Alonso MJ
Eur J Pharm Sci; 2010 Dec; 41(5):644-9. PubMed ID: 20869438
[TBL] [Abstract][Full Text] [Related]
28. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
[TBL] [Abstract][Full Text] [Related]
29. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
Patil GB; Surana SJ
J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
[TBL] [Abstract][Full Text] [Related]
30. In vivo tissue distribution and efficacy studies for cyclosporin A loaded nano-decorated subconjunctival implants.
Yavuz B; Bozdağ Pehlivan S; Kaffashi A; Çalamak S; Ulubayram K; Palaska E; Çakmak HB; Ünlü N
Drug Deliv; 2016 Nov; 23(9):3279-3284. PubMed ID: 27027148
[TBL] [Abstract][Full Text] [Related]
31. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
[TBL] [Abstract][Full Text] [Related]
32. Dual-layer surface coating of PLGA-based nanoparticles provides slow-release drug delivery to achieve metronomic therapy in a paclitaxel-resistant murine ovarian cancer model.
Amoozgar Z; Wang L; Brandstoetter T; Wallis SS; Wilson EM; Goldberg MS
Biomacromolecules; 2014 Nov; 15(11):4187-94. PubMed ID: 25251833
[TBL] [Abstract][Full Text] [Related]
33. Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation.
Widmer J; Thauvin C; Mottas I; Nguyen VN; Delie F; Allémann E; Bourquin C
Int J Pharm; 2018 Jan; 535(1-2):444-451. PubMed ID: 29157965
[TBL] [Abstract][Full Text] [Related]
34. In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid.
Booysen LL; Kalombo L; Brooks E; Hansen R; Gilliland J; Gruppo V; Lungenhofer P; Semete-Makokotlela B; Swai HS; Kotze AF; Lenaerts A; du Plessis LH
Int J Pharm; 2013 Feb; 444(1-2):10-7. PubMed ID: 23357255
[TBL] [Abstract][Full Text] [Related]
35. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
Yu DH; Lu Q; Xie J; Fang C; Chen HZ
Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
[TBL] [Abstract][Full Text] [Related]
36. Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and/or doxycycline for treatment of periodontitis.
Gad HA; El-Nabarawi MA; Abd El-Hady SS
AAPS PharmSciTech; 2008; 9(3):878-84. PubMed ID: 18654864
[TBL] [Abstract][Full Text] [Related]
37. Formation and characterization of chitosan-polylacticacid-polyethylene glycol-gelatin nanoparticles: a novel biosystem for controlled drug delivery.
Rajan M; Raj V
Carbohydr Polym; 2013 Oct; 98(1):951-8. PubMed ID: 23987433
[TBL] [Abstract][Full Text] [Related]
38. Vectorization of copper complexes via biocompatible and biodegradable PLGA nanoparticles.
Courant T; Roullin VG; Cadiou C; Delavoie F; Molinari M; Andry MC; Gafa V; Chuburu F
Nanotechnology; 2010 Apr; 21(16):165101. PubMed ID: 20348590
[TBL] [Abstract][Full Text] [Related]
39. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
Parveen S; Sahoo SK
Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
[TBL] [Abstract][Full Text] [Related]
40. Physicochemical characterization of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier.
Kim IS; Lee SK; Park YM; Lee YB; Shin SC; Lee KC; Oh IJ
Int J Pharm; 2005 Jul; 298(1):255-62. PubMed ID: 15941631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
